α-1,4-Glucosidase–albumin polymers : in vitro properties and advantages for enzyme replacement therapy
- 1 March 1980
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 58 (3) , 322-325
- https://doi.org/10.1139/y80-056
Abstract
Soluble polymers of rat (or human) albumin and α-1,4-glucosidase are prepared using the cross-linking agent glutaraldehyde. The resulting polymer has an average molecular weight of 800 000 indicating an average composition of 12 albumin molecules for each enzyme molecule. Compared with an equivalent amount of free enzyme, the enzyme–albumin polymer has an increased resistance to heat denaturation (half-life of 15 h compared with 1 h for free enzyme at 37 °C) and to proteolysis by trypsin (half-life of 180 min compared with 10 min). The high degree of resistance to bioinactivation of the enzyme–albumin polymer is discussed in relation to requirements for enzyme replacement therapy in a range of metabolic diseases including type II glycogenosis (Pompe's disease) where α-1,4-glucosidase is the defective enzyme.This publication has 5 references indexed in Scilit:
- In vitro and in vivo activity of soluble cross-linked uricase-albumin polymers: A model for enzyme therapyLife Sciences, 1979
- The Carrier Potential of Liposomes in Biology and MedicineNew England Journal of Medicine, 1976
- Papain-collodion membranes. I. Preparation and propertiesBiochemistry, 1968
- ELECTRON MICROSCOPIC + BIOCHEMICAL STUDY OF TYPE 2 GLYCOGENOSIS1964
- The purification and properties of an α-glucoside of Saccharomyces italicus Y1225Biochimica et Biophysica Acta, 1958